Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × Everolimus × Clear all

NCT01035229 2016-09-22

EVOLVE-1

Phase 3 Completed

546 enrolled 18 charts

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular